Hinge Health (HNGE) EBIT (2024 - 2026)

Hinge Health has disclosed EBIT across 3 years of filings, most recently posting $32.1 million for Q1 2026.

• EBIT for Q1 2026 came in at $32.1 million, up 144.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$527.4 million (down 4269.15% YoY), and the FY2025 annual result was -$546.4 million, down 1612.23% from the prior year.
• EBIT came in at $32.1 million for Q1 2026 at Hinge Health, up from $27.3 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $32.1 million in Q1 2026 to a low of -$580.7 million in Q2 2025.
• The 3-year median for EBIT is $4.6 million (2024), against an average of -$64.3 million.
• Across the five-year window, EBIT slumped 3208.48% in 2025 and soared 144.11% in 2026, its largest moves.
• Hinge Health's EBIT stood at $20.9 million in 2024, then soared by 30.35% to $27.3 million in 2025, then climbed by 17.66% to $32.1 million in 2026.
• The last three EBIT figures came in at $32.1 million (Q1 2026), $27.3 million (Q4 2025), and -$6.1 million (Q3 2025), per Business Quant data.